Sectoral Asset Management Inc Bio Atla, Inc. Transaction History

Sectoral Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.7 - $3.07 $254,224 - $459,100	149,544 Added 26.87%	706,062 $1.2 Million
Q2 2023 Aug 11, 2023	BUY	$2.83 - $3.87 $38,230 - $52,279	13,509 Added 2.49%	556,518 $1.67 Million
Q1 2023 May 12, 2023	BUY	$2.3 - $8.25 $930,844 - $3.34 Million	404,715 Added 292.65%	543,009 $1.46 Million
Q4 2022 Feb 10, 2023	BUY	$7.63 - $11.01 $1.06 Million - $1.52 Million	138,294 New	138,294 $1.14 Million

24.8M

140K

4.6K

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $47.9M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.